134 related articles for article (PubMed ID: 10555183)
1. Glucose and methionine uptake and proliferative activity in meningiomas.
Iuchi T; Iwadate Y; Namba H; Osato K; Saeki N; Yamaura A; Uchida Y
Neurol Res; 1999 Oct; 21(7):640-4. PubMed ID: 10555183
[TBL] [Abstract][Full Text] [Related]
2. Correlation of
Mitamura K; Yamamoto Y; Norikane T; Hatakeyama T; Okada M; Nishiyama Y
Ann Nucl Med; 2018 Nov; 32(9):627-633. PubMed ID: 30032455
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET.
Chung JK; Kim YK; Kim SK; Lee YJ; Paek S; Yeo JS; Jeong JM; Lee DS; Jung HW; Lee MC
Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):176-82. PubMed ID: 11926379
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
Tsuyuguchi N
Osaka City Med J; 1997 Dec; 43(2):209-23. PubMed ID: 9540343
[TBL] [Abstract][Full Text] [Related]
5. 11C-Methionine Positron Emission Tomography/Computed Tomography Versus 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Evaluation of Residual or Recurrent World Health Organization Grades II and III Meningioma After Treatment.
Tomura N; Saginoya T; Goto H
J Comput Assist Tomogr; 2018; 42(4):517-521. PubMed ID: 29613985
[TBL] [Abstract][Full Text] [Related]
6. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
[TBL] [Abstract][Full Text] [Related]
7. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study.
Di Chiro G; Hatazawa J; Katz DA; Rizzoli HV; De Michele DJ
Radiology; 1987 Aug; 164(2):521-6. PubMed ID: 3496626
[TBL] [Abstract][Full Text] [Related]
8. Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.
Pirotte B; Goldman S; Massager N; David P; Wikler D; Lipszyc M; Salmon I; Brotchi J; Levivier M
J Neurosurg; 2004 Sep; 101(3):476-83. PubMed ID: 15352606
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of meningiomas assessed by ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron-emission tomography.
Arita H; Kinoshita M; Okita Y; Hirayama R; Watabe T; Ishohashi K; Kijima N; Kagawa N; Fujimoto Y; Kishima H; Shimosegawa E; Hatazawa J; Hashimoto N; Yoshimine T
J Neurooncol; 2012 Apr; 107(2):379-86. PubMed ID: 22089887
[TBL] [Abstract][Full Text] [Related]
10. Monosomy 1p is correlated with enhanced in vivo glucose metabolism in meningiomas.
Henn W; Cremerius U; Heide G; Lippitz B; Schröder JM; Gilsbach JM; Büll U; Zang KD
Cancer Genet Cytogenet; 1995 Feb; 79(2):144-8. PubMed ID: 7889508
[TBL] [Abstract][Full Text] [Related]
11. 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Astner ST; Adam M; Krause BJ; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):339-44. PubMed ID: 16765533
[TBL] [Abstract][Full Text] [Related]
12. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
13. Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET.
Roelcke U; Radü EW; von Ammon K; Hausmann O; Maguire RP; Leenders KL
J Neurol Sci; 1995 Sep; 132(1):20-7. PubMed ID: 8523026
[TBL] [Abstract][Full Text] [Related]
14. Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET.
Cremerius U; Bares R; Weis J; Sabri O; Mull M; Schröder JM; Gilsbach JM; Buell U
J Nucl Med; 1997 Jan; 38(1):26-30. PubMed ID: 8998144
[TBL] [Abstract][Full Text] [Related]
15. Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine.
Ogawa T; Inugami A; Hatazawa J; Kanno I; Murakami M; Yasui N; Mineura K; Uemura K
AJNR Am J Neuroradiol; 1996 Feb; 17(2):345-53. PubMed ID: 8938309
[TBL] [Abstract][Full Text] [Related]
16. 1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery.
Liu RS; Chang CP; Guo WY; Pan DH; Ho DM; Chang CW; Yang BH; Wu LC; Yeh SH
J Nucl Med; 2010 Jun; 51(6):883-91. PubMed ID: 20484430
[TBL] [Abstract][Full Text] [Related]
17. PET-study of intracranial meningiomas: correlation with histopathology, cellularity and proliferation rate.
Lippitz B; Cremerius U; Mayfrank L; Bertalanffy H; Raoofi R; Weis J; Böcking A; Büll U; Gilsbach JM
Acta Neurochir Suppl; 1996; 65():108-11. PubMed ID: 8738510
[TBL] [Abstract][Full Text] [Related]
18. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
19. Parapharyngeal meningioma extending from the intracranial space evaluated by FDG PET.
Kado H; Ogawa T; Okudera T; Kanno I; Hatazawa J; Uemura K
J Nucl Med; 1998 Feb; 39(2):302-4. PubMed ID: 9476940
[TBL] [Abstract][Full Text] [Related]
20. 13N-NH3 versus F-18 FDG in detection of intracranial meningioma: initial report.
Xiangsong Z; Xingchong S; Chang Y; Xiaoyan W; Zhifeng C
Clin Nucl Med; 2011 Nov; 36(11):1003-6. PubMed ID: 21975388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
